You are here:
Home
NICE Guidance
Conditions and diseases
Infections
Skin infections
Ruxolitinib for Prurigo Nodularis [ID6571]
Awaiting development
Reference number:
GID-TA11760
Expected publication date: TBC
Project information
Project documents
To appraise the clinical and cost effectiveness of Ruxolitinib within its marketing authorisation for treating prurigo nodularis ID6571
Back to top